Loading chat...
MN HF2999
Bill
Status
3/20/2023
Primary Sponsor
Robert Bierman
Click for details
AI Summary
-
Dispensers must correct errors in prescription monitoring program data identified during submission within seven calendar days, and must notify patients or their representatives of reported data and its use for program administration.
-
Licensed dispensing practitioners and licensed pharmacists gain access to the prescription monitoring program database to determine whether corrections to reported data are accurate.
-
Prescribers must access prescription monitoring program data before issuing initial prescriptions for Schedule II-IV opiates and at least every three months for patients receiving opiates for chronic pain or medically assisted treatment, with specific exceptions for palliative care, cancer treatment, and post-surgical prescriptions.
-
Board of Pharmacy personnel and contractors are added to permissible users who may directly access program data electronically, subject to information security requirements and data de-identification standards.
-
$753,500 is appropriated from the general fund to the Board of Pharmacy for fiscal year 2024 for the Minnesota prescription monitoring program, available until June 30, 2025.
Legislative Description
Minnesota prescription monitoring program reporting requirements and immunity from liability modified, Minnesota prescription monitoring program access expanded to allow pharmacists or dispensing practitioners to correct errors in program, program funding continued, and money appropriated.
Last Action
Introduction and first reading, referred to Health Finance and Policy
3/20/2023